XML 54 R43.htm IDEA: XBRL DOCUMENT v3.4.0.3
Collaborative and Other Agreements (Narrative) (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2016
Sep. 30, 2015
Mar. 31, 2015
Dec. 31, 2013
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Licensing Payments Received $ 106,000   $ 102,000  
Intrexon Corporation [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Fees Payable Upon Commencement Of The First Phase 2 Trial 2,500,000      
Fees Payable Upon First Regulatory Approval 5,000,000      
Expenses Incurred Under Channel Collaborative Agreement 54,000   22,000  
Cash Paid For Channel Collaboration Agreement 56,000   3,000  
Liability for amounts due to terminated channel collaboration partner 54,000      
University Of Leicester [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Expenses Incurred Under Channel Collaborative Agreement 43,000   35,000  
Cash Paid For Channel Collaboration Agreement 46,000   50,000  
University Of Glasgow [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Payments For Services Under Collaborative Agreement     13,000  
Expenses Incurred Under Channel Collaborative Agreement 0      
Cash Paid For Channel Collaboration Agreement 0   61,000  
Walter Reed Army Institute Of Research [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Payments For Services Under Collaborative Agreement 0   $ 0  
Takara Bio Inc [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Licensing Payments Received   $ 40,000    
Patent license agreement revenue $ 4,000      
Takara Bio Inc [Member] | Nonsoftware License Arrangement [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Percent of License Product Sales Receivable 12.00%      
Percent of License Product Service Revenues Receivable 6.00%      
Minimum Annual Royalty Payments Receivable $ 15,000      
Takara Bio Inc [Member] | Nonsoftware License Arrangement [Member] | Criteria One [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Contingent Licensing Receivable 30,000      
Licensed Product Revenues Milestone Benchmark 1,000,000      
Takara Bio Inc [Member] | Nonsoftware License Arrangement [Member] | Criteria Two [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Contingent Licensing Receivable 40,000      
Licensed Product Net Sales Milestone Benchmark $ 2,000,000      
Common Stock [Member] | Intrexon Corporation [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Stock Issued During Period, Value, Issued for Services       $ 3,000,000